Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium-Reference-Cited by-同舟云学术

Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium

Published:2012-07-30 Issue:7 Volume:206 Page:1030-1040
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:Journal of Infectious Diseases

Author:

Dorman S. E.,Goldberg S.,Stout J. E.,Muzanyi G.,Johnson J. L.,Weiner M.,Bozeman L.,Heilig C. M.,Feng P.-J.,Moro R.,Narita M.,Nahid P.,Ray S.,Bates E.,Haile B.,Nuermberger E. L.,Vernon A.,Schluger N. W.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/206/7/1030/2417623/jis461.pdf

Reference37 articles.

1. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

2. BACTERIOLOGIC BASIS OF SHORT-COURSE CHEMOTHERAPY FOR TUBERCULOSIS

3. Bactericidal ActivityIn Vitroof Various Rifamycins againstMycobacterium aviumandMycobacterium tuberculosis

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification;2024-05-07

2. Efficacy and Safety Rifapentine-Containing Regimen for Drug Sensitive Tuberculosis: Systematic Review and Meta-Analysis;Pneumon;2024-04-26

3. Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease;Nature Reviews Drug Discovery;2024-02-28

4. Pretrained Regression Adjustment With An Application to Clinical Trials;2024

5. Development and validation of stability indicating high‐performance thin‐layer chromatographic method for estimation of Rifapentine in pharmaceutical formulation;SEPARATION SCIENCE PLUS;2023-11-20